Methods for in vitro inhibition of fibroblast proliferation
AssigneesThe Research Foundation of State University of New York, The Regents of the University of California
InventorsJared Jagdeo, Roslyn Rivkah Isseroff, Andrew Mamalis, Neil Brody, Daniel Siegel, Hadar Lev-Tov
Life of this patent
Estimating the term…
Abstract
Methods for LED generated low-level light therapy (LLLT) in the red, blue, and IR ranges are described to effectively inhibit fibroblast proliferation in vitro without altering viability, and may be used as therapy for the treatment of scars and other proliferative skin diseases.
Claims20
A method for treating human skin fibroblasts, the method comprising:
- directing visible light into a target region of skin tissue;
- and
- exposing the skin tissue to a therapeutic dose of visible light sufficient to decrease fibroblast proliferation within said target region of skin tissue.
A method for treating human skin fibroblasts, the method comprising:
- directing infrared light into a target region of skin tissue;
- and
- exposing the skin tissue to a therapeutic dose of infrared light sufficient to decrease fibroblast proliferation within said target region of skin tissue.
A method for treating human skin fibroblasts, the method comprising:
- directing visible red light into a target region of skin tissue;
- and
- exposing the skin tissue to a therapeutic dose of red light sufficient to decrease fibroblast proliferation within said target region of skin tissue.
Dependencies are inferred from the claim text.